UNIQURE N.V. : Other Events, Financial Statements and Exhibits (form 8-K)

Item 8.01 Other Events.

On November 22, 2022, uniQure N.V. issued a press release announcing the approval by the U.S. Food and Drug Administration of HEMGENIX (etranacogene dezaparvovec). A copy of the press release is attached to this Current Report on Form 8-K as Exhibit 99.1 and incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.

(d)    Exhibit



Exhibit No.                              Description
    99.1       Press Release of uniQure N.V. dated November 22, 2022 the
             approval by the U.S. Food and Drug Administration of HEMGENIX
             (etranacogene dezaparvovec).

    104      Cover Page Interactive Data File (embedded with the Inline XBRL
             document).

© Edgar Online, source Glimpses